The success of antiretroviral therapy (ART) has transformed HIV from a fatal diagnosis into a manageable chronic condition, but this triumph has brought a new set of clinical challenges. As people living with HIV (PWH) age, the global medical community must pivot from a narrow focus on viral suppression to a comprehensive framework for healthy longevity.

The recently published Lancet HIV Commission outlines a roadmap for this transition, warning that current healthcare systems are ill-equipped for the "graying" of the epidemic.

A Global Demographic Shift

Ageing with HIV is no longer a niche concern for high-income nations; it is a global health priority. By 2025, approximately 11.5 million PWH will be over the age of 50.

Forecasts suggest that by 2040, the median age of adults living with HIV will reach 50, and over half of the global HIV population—some 20.2 million people—will be aged 50 or older.

Crucially, 96% of these older individuals are expected to reside in low-income and middle-income countries (LMICs), where healthcare infrastructure is often most strained.

Major Findings and Challenges

The Commission identifies a "triple threat" facing older PWH: multimorbidity, polypharmacy, and intersectional stigma.

Older adults are often diagnosed later in the disease course, leading to higher mortality and increased physiological injury. Furthermore, vertical healthcare models—those that treat HIV in isolation—fail to address the complex needs of patients managing cardiovascular disease, diabetes, and geriatric syndromes alongside their infection.

Polypharmacy remains a significant risk, as age-related changes in hepatic and renal function alter drug metabolism, increasing the likelihood of toxicities and drug-drug interactions.

A Three-Phase Clinical Framework

1. Establishment (6–12 months): Focus on initiating a well-tolerated ART regimen and building a therapeutic alliance.
2. Maintenance (>10 years expected survival): Transition toward screening and treating comorbid diseases, monitoring physiological age rather than just chronological years.
3. Function (<10 years expected survival): Pivot toward maintaining physical and cognitive function, prioritizing what matters most to the patient over a "checklist" mentality for individual diseases.

Key Recommendations

The Commission calls for the "diagonalisation" of healthcare, which involves integrating HIV services into broader chronic disease management or strengthening referrals between existing vertical silos.

Clinicians should move toward using validated tools, like the VACS Index, to assess physiological age and remaining survival, as chronological age is often a poor proxy for risk in PWH.

The report also emphasizes leveraging digital health and community-based "social prescribing" to combat isolation and support self-care.

Take-Home Message for Clinicians

For the modern HIV specialist, success is no longer defined solely by an undetectable viral load.

Healthy ageing requires proactive management of non-communicable diseases, a reduction in unnecessary medications, and a deep focus on preserving a patient's functional independence and dignity.

Conclusion

The HIV response is at a crossroads. If we are to honor the "miracle" of ART, we must evolve our systems to support patients not just to survive, but to age well across an extended lifespan.

References

1. The Lancet HIV Commission on ageing and HIV: a global perspective.
2. Justice AC, Althoff KN, Clarfield AM, et al. The Lancet HIV Commission on ageing and HIV: a global perspective. Lancet HIV 2026; published online July 27.